For decades, red light therapy has been an adjunct treatment for numerous ailments. But it may not work for all the medical ...

Imperial College London’s Fleming Initiative, named after the discoverer of the first antibiotic, penicillin, is an international effort that aims to stymie the spread of these germs, but they ...

Current decolonization methods for methicillin-resistant Staphylococcus aureus (MRSA) face several challenges, including resistance development or microbiome disruption. Hypharm GmbH has presented ...

Superbugs, which are antibiotic-resistant infections, are on the rise globally. Experts say the UK isn't doing enough to ...

The first episode of the "Living with Netherton” series will be released on Rare Disease Day, Feb. 28, 2025, with the video ...

A recent AI breakthrough, which took just two days to crack what a scientist had been working on for ten years, is having a ...

British physician and microbiologist Alexander Fleming, discoverer of penicillin nearly 100 years ago, was the first to warn ...

Metaba, LLC ( and MAX BioPharma, Inc. ( are pleased to announce significant progress in their collaboration to develop ...

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...

The following is a summary of “Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA ...

A mom has said her 11-day-old daughter died from an infection at an 'absolutely putrid' hospital at an inquiry into the ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...